Siegfried Expands Production Capacity in El Masnou
Siegfried announced a further expansion of its ophthalmic drug manufacturing site in El Masnou near Barcelona, Spain.
Contract Development And Manufacturing Organizations (CDMO)
Motivation, Innovation, and the Power of Collaboration
Leading the Way in Pharmaceutical Manufacturing by Fostering an Agile Mindset and an Inclusive Culture.
Hovione and Firstgene Announce Strategic Collaboration
Exclusive licensing and R&D collaboration between Hovione and Firstgene.
Aenova Launches Program to Accelerate Pharmaceutical Development
Aenova announces the launch of its Aenovation program. This initiative aims to accelerate the early development of pharmaceutical formulations.
Bionova Licenses Technologies from ATUM
Bionova Scientific, an Asahi Kasei boutique commercial-scale biologics contract development and manufacturing organization (CDMO), has licensed ATUM’s proprietary Leap-In Transposase transposon-based gene delivery and its miCHO cell line development technologies.
PCI Pharma Services Acquires Ajinomoto Althea
PCI Pharma Services has completed its acquisition of Ajinomoto Althea, a CDMO subsidiary of Ajinomoto.
Fujifilm Diosynth Biotechnologies & Regeneron Sign Manufacturing Agreement
Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced a 10-year manufacturing supply agreement, valued at over $3 billion (€2.64 billion), with Regeneron Pharmaceuticals to provide US-based production of its industry-leading biologic medicines, which treat millions of patients worldwide.
Suanfarma Appoints Pere Mañé as New CEO
CDMO Suanfarma appoints Pere Mañé Godina as its new CEO, marking the beginning of a new chapter for the company, focused on industrial consolidation, sustainable innovation, and global expansion.
Meribel Pharma Solutions Launches
A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions, has launched today with an extensive integrated network across Europe.
HAS Acquires Cerbios-Pharma
HAS Healthcare Advanced Synthesis (HAS) recently announced the planned acquisition of Cerbios-Pharma (Cerbios), a globally recognized manufacturer of chemical and biological APIs, including antibody-drug conjugates (ADCs).
Syngene Acquires its First US Manufacturing Facility
Syngene, a global contract research, development, and manufacturing organization (CRDMO), recently announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines.
Axplora Expands Capabilities at Le Mans Site
Axplora, an API small molecule and ADC (antibody-drug conjugate) manufacturer, is strengthening its position in the commercial manufacturing ADCs by launching a cutting-edge payload manufacturing workshop at its Le Mans site (France).
Adragos Pharma Commissions New Liquid Filling Line at German Site
German contract development and manufacturing organization (CDMO) Adragos Pharma has completed a €4 million project to install and commission a new, cGMP-compliant liquid drug filling line and associated cartoning machine at its plant in Leipzig, Germany.
CordenPharma Expands Peptide Manufacturing Platform in Switzerland
Contract development and manufacturing organization (CDMO) CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in Muttenz near Basel. This investment is part of the company’s growth initiatives with a more than €1 billion strategic investment in peptide development and manufacturing.
Granules India Buys Swiss CDMO Senn Chemicals
Indian pharmaceutical company Granules India has agreed to acquire Senn Chemicals, a Swiss-based contract development and manufacturing organization (CDMO) specializing in peptides. The closing of the deal, which is subject to certain conditions, is expected to occur in the first half of 2025. Financial details of the transaction were not disclosed.
Jabil Acquires CDMO Pharmaceutics International
Jabil, a global provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International (Pii), a US contract development and manufacturing organization (CDMO) specializing in early-stage, clinical, and commercial volume aseptic filling, lyophilization, and oral solid dose manufacturing. Financial details of the transaction, which was completed on Feb. 3, 2025, were not given.
Upperton Completes Sterile Manufacturing Facility in UK
UK contract development and manufacturing organization (CDMO) Upperton Pharma Solutions, has completed its new sterile manufacturing facility in Nottingham, UK, expanding its capacity in addition to its existing 50,000-square-foot site at Trent Gateway.
Solvias Opens New Testing Center in North Carolina, US
Solvias, a Switzerland-headquartered provider of chemistry, manufacturing, and control (CMC) analytics, has opened the first phase of its 50,000-square-foot testing center for biologics and cell and gene therapy in Research Triangle Park (RTP), North Carolina, US.
Alcami Announces CEO Transition
Alcami, a contract development and manufacturing organization (CDMO), recently announced the resignation of its CEO, Bill Humphries. Alcami’s Board Chair and former CEO Patrick Walsh will serve as Interim CEO, ensuring the continuation of smooth operations.
Lonza Outlines Restructuring Strategy and New Organizational Structure
At an investor update at the end of last week, Lonza has announced its "One Lonza" restructuring strategy, which aims to reorganize its CDMO business, simplify its operating model, enhance manufacturing and engineering, and expand its production footprint.
Substantial Progresses in Sustainability Focus Areas
The Italian Olon Group, a leading international supplier of active pharmaceutical ingredients (APIs), presents the 2023 Corporate Sustainability Report and confirms the sustainability journey toward energy transition, investments in alternative energy sources, social and economic involvement and support for the communities in which it operates
SOCMA Publishes 2025 Contract Manufacturing Outlook
The Society of Chemical Manufacturers & Affiliates (SOCMA) has published the results of its 2025 Contract Manufacturing Outlook survey which reveals significant trends and insights into the contract manufacturing landscape.
Hovione Expands Spray Drying Capacities in the USA and Ireland
Lisbon, Portugal-headquartered Hovione has completed significant expansions in Europe and the USA. The investments at the facilities in East Windsor, New Jersey, and Ringaskiddy, Cork, significantly increase the global capacities of the CDMO (contract development and manufacturing organization) for spray drying for pharma applications and improve the sites' capabilities.
Samsung Biologics Signs Manufacturing Deal with European Pharmaceutical Company
Samsung Biologics, a global contract development and manufacturing organization (CDMO), recently announced a series of manufacturing deals with a Europe-based pharmaceutical company.
Avantor Opens New US Innovation Center in Bridgewater
Avantor has opened its latest Innovation Center in Bridgewater, New Jersey, US, “to support the growing demands for monoclonal antibodies, cell and gene therapy and mRNA workflows.” The new center is now part of the company’s network of 13 global research and innovation centers.
Siegfried Opens New Drug Substances R&D Center in Evionnaz
Zofingen, Switzerland-based contract development and manufacturing organization (CDMO) Siegfried inaugurated its new global research and development (R&D) center for drug substances at its site in Evionnaz, Switzerland. The 4,500 m2 center houses chemical and analytical facilities, laboratories, and technologies such as flow chemistry, advanced distillation and process analytical technology, as well as new office space.
Lonza to Expand Bioconjugation in Visp, Switzerland
Lonza, a global contract development and manufacturing organization (CDMO) for the pharmaceutical, biotech, and nutraceutical markets, announced today that it will invest in additional bioconjugation capabilities in Visp, Switzerland.
Avid Bioservices to Be Acquired by GHO Capital and Ampersand
US-headquartered Avid Bioservices, a biologics-oriented CDMO, will be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners in an all-cash transaction valued at approximately $1.1 billion. The three companies have signed a corresponding agreement.
Ardena Expands European Bioanalytical Capabilities
Belgium-headquartered pharmaceutical contract development and manufacturing organization (CDMO) Ardena announced plans to expand its bioanalytical services in the Netherlands. As part of the investment, the company plans to establish a new bioanalytical laboratory at its Pivot Park facility in Oss, as well as additional capacity and new GLP capabilities at its bioanalytical center of excellence in Assen.
Sterling Pharma Solutions Expands GMP ADC Manufacturing Capacity
Sterling Pharma Solutions, a global contract development and manufacturing organization (CDMO), today announced the second phase of an expansion strategy at its Deeside, UK site to support antibody-drug conjugate (ADC) development, with a more than £10 million (€11.9 million) investment to increase GMP bioconjugation capacity.
Rentschler Plans New Buffer Media Facility at its Headquarters
In a move to further increase production efficiency and modernize the site, German contract development and manufacturing organization (CDMO) Rentschler Biopharma plans to construct a new buffer media station at its company headquarters in Laupheim. According to Rentschler, this is the largest single investment in the German site.
Cambrex Opens New Stability Storage Facility
Today, Cambrex announced its stability storage business, Q1 Scientific, and opened a new cGMP facility in Durham, North Carolina, expanding its capacity for environmentally controlled stability storage services to North America's pharmaceutical, medical device, and life sciences industries.
Specialty Pharma CDMO OneSource Recently Launched
OneSource Specialty Pharma, a newly incorporated CDMO, formed from the merger of three CDMO businesses within the Strides Group. The company has a 30-year track record and specializes in biologics, drug-device combinations, and soft gelatin capsules.
Piramal to Expand US Facility for Sterile Injectables
US contract development and manufacturing organization (CDMO) Piramal Pharma Solutions (PPS), part of India-headquartered Piramal Pharma, plans to invest $80 million for the expansion of its Lexington, Kentucky, facility.
Cambrex Announces New Peptide Synthesis Manufacturing Technology
Cambrex announced that Snapdragon Chemistry, a Cambrex company, has developed a new liquid-phase peptide synthesis (LPPS) technology utilizing active pharmaceutical ingredient (API) batch reactors and continuous flow.
